As the development and marketing of antimicrobial agents, some experts had predicted that the infectious diseases would be under control and even eradicated. However, this is not the truth. Infectious diseases become more and more difficult to manage because of rapid increased drug resistance among important pathogens after the overuse of antimicrobial agents and introduction of invasive procedures as well as immunosuppression therapy. Till now, treatment of infectious diseases remains the important clinical issues with great challenge. To overcome the drug resistance, wisely using the currently available antimicrobial agents, development of new antimicrobial agents and diagnostic tools, and introduction of new vaccines to increase hosts’ immunity and to protect the immunized hosts against active diseases are all necessary strategies. However, to facilitate the marketing of new antimicrobial agents, vaccines, and diagnostic tools and to confirm their efficacies, conducting relevant clinical trials are mandatory. Establishing a clinical trials consortium of infectious diseases is an important method to facilitate the conduction of related clinical studies. A consortium can attract international pharmaceutical, biotechnology, and vaccine companies to perform international, multicenter clinical trials on new products related to infectious diseases in Taiwan, help domestic companies conduct new drug clinical trials, and also support researchers initiated clinical studies. The present program intends to establish the Taiwan Clinical Trial Consortium of Infectious Diseases by integrate infectious diseases specialists from 10 Taiwanese hospitals and microbiologists from 3 basic science research centers to make Taiwan become more competitive in participating international multicenter clinical trials. This consortium will also help Taiwan companies to conduct new products clinical trials and support the researchers initiated clinical studies.

Setting up Taiwan Infectious Disease Consortium and Databank of Infectious Diseases (I) = 建立台灣感染症臨床試驗聯盟及感染症相關資料庫 (I)

關於 (About)

聯絡資訊 (Contact Us)

相關網站 (Useful Links)

關於開放取用 (Open Access, OA)

出版社期刊論文授權政策 (Copyright)

使用說明 (Instructions)

登入說明 (Sign-in)

匯入著作 (Submission)